
    
      Pembrolizumab will be given at a dose of 200 mg q3 weeks (this is the standard dosage, ), and
      vemurafenib/cobimetinib will be given at 480 mg twice daily/20 mg daily, 720 mg twice
      daily/40 mg daily, or 960 mg twice daily/60 mg daily. Treatment with pembrolizumab,
      vemurafenib and cobimetinib will commence on the same day.
    
  